Skip to content

DERMAX: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

DERMAX

BE 0667.730.677
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€517,589
2024 · €2.6m-€2.1m
Equity
€5.3m
2024 · €4.8m+€517,589
Cash
€168,229
2024 · €257,494-€89,265
Balance sheet total
€5.7m
2024 · €6.6m-€823,874

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€858,897

    down €858,897 (-23.7%), from €3.6m to €2.8m

    of which Trade receivables: -€1.7m

  • Cash -€89,265

    down €89,265 (-34.7%), from €257,494 to €168,229

    mainly Trade debts (-€1.2m) and Investment in fixed assets (net) (-€308,788)

  • Receivables after one year +€78,649

    new in 2025: €78,649

Equity and liabilities
  • Trade debts -€1.2m

    down €1.2m (-73.6%), from €1.6m to €414,335

  • Profit (loss) carried forward +€517,589

    up €517,589 (+35.3%), from €1.5m to €2.0m

  • Accrued charges and deferred income -€149,810

    no longer reported in 2025 (was €149,810)

Income statement
  • Gross operating margin -€2.1m

    down €2.1m (-63.6%), from €3.3m to €1.2m

  • Turnover +€1.6m

    new in 2025: €1.6m

  • Purchases and services +€810,536

    up €810,536 (+16246.5%), from €4,989 to €815,525

  • Taxes +€295,445

    up €295,445 (+296.5%), from €99,633 to €395,078

  • Depreciation -€174,480

    down €174,480 (-39.9%), from €437,629 to €263,149

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €2.6m
Gross operating margin -€2.1m
Depreciation +€174,480
Other operating charges +€34
Financial income -€14,321
Financial charges +€122,472
Taxes -€295,445
Result 2025 €517,589

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€219,523
Investment -€308,788
Financing €0
Cash 2024 €257,494
Net result for the year +€517,589
Depreciation +€263,149
Receivables after one year -€78,649
Receivables within one year +€858,897
Trade debts -€1.2m
Tax, wage and social debts -€36,066
Accrued charges and deferred income -€149,810
Investment in fixed assets (net) -€308,788
Cash 2025 €168,229
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €6,550,807 €5,726,933 -€823,874 -12.6%
Fixed assets 21/28 €2,665,712 €2,711,351 +€45,639 +1.7%
Intangible fixed assets 21 €2,665,712 €2,711,351 +€45,639 +1.7%
Current assets 29/58 €3,885,095 €3,015,582 -€869,513 -22.4%
Amounts receivable after more than one year 29 - €78,649 +€78,649
Other amounts receivable 291 - €78,649 +€78,649
Amounts receivable within one year 40/41 €3,627,601 €2,768,704 -€858,897 -23.7%
Trade receivables 40 €3,184,837 €1,477,025 -€1.7m -53.6%
Other amounts receivable 41 €442,764 €1,291,679 +€848,915 +191.7%
Cash at bank and in hand 54/58 €257,494 €168,229 -€89,265 -34.7%
Total equity and liabilities 10/49 €6,550,807 €5,726,933 -€823,874 -12.6%
Equity 10/15 €4,795,009 €5,312,598 +€517,589 +10.8%
Contributions 10/11 €3,250,022 €3,250,022 = 0.0%
Capital 10 €2,183,505 €2,183,505 = 0.0%
Issued capital 100 €2,183,505 €2,183,505 = 0.0%
Outside capital 11 €1,066,517 €1,066,517 = 0.0%
Share premium 1100/10 €1,066,517 €1,066,517 = 0.0%
Reserves 13 €77,249 €77,249 = 0.0%
Non-distributable reserves 130/1 €77,249 €77,249 = 0.0%
Legal reserve 130 €77,249 €77,249 = 0.0%
Profit (loss) carried forward 14 €1,467,738 €1,985,327 +€517,589 +35.3%
Amounts payable 17/49 €1,755,798 €414,335 -€1.3m -76.4%
Amounts payable within one year 42/48 €1,605,988 €414,335 -€1.2m -74.2%
Trade debts 44 €1,569,922 €414,335 -€1.2m -73.6%
Suppliers 440/4 €1,569,922 €414,335 -€1.2m -73.6%
Taxes, remuneration and social security 45 €36,066 - -€36,066
Taxes 450/3 €36,066 - -€36,066
Accrued charges and deferred income 492/3 €149,810 - -€149,810
Turnover 70 - €1,554,264 +€1.6m
Goods, raw materials, services and sundry goods 60/61 €4,989 €815,525 +€810,536 +16246.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €437,629 €263,149 -€174,480 -39.9%
Other operating charges 640/8 €1,473 €1,439 -€34 -2.3%
Gross operating margin 9900 €3,302,198 €1,202,474 -€2.1m -63.6%
Operating profit (loss) 9901 €2,863,096 €937,886 -€1.9m -67.2%
Financial income 75/76B €45,668 €31,347 -€14,321 -31.4%
Recurring financial income 75 €45,668 €31,347 -€14,321 -31.4%
Financial charges 65/66B €179,038 €56,566 -€122,472 -68.4%
Recurring financial charges 65 €179,038 €56,566 -€122,472 -68.4%
Profit (loss) for the period before taxes 9903 €2,729,726 €912,667 -€1.8m -66.6%
Income taxes 67/77 €99,633 €395,078 +€295,445 +296.5%
Profit (loss) for the period 9904 €2,630,093 €517,589 -€2.1m -80.3%
Profit (loss) for the period to be appropriated 9905 €2,630,093 €517,589 -€2.1m -80.3%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 September 2026 via checked.be.